Back to Results
First PageMeta Content
Health / Pharmaceutical industry / Generic drug / Public domain / Pharmacy benefit management / Drug Price Competition and Patent Term Restoration Act / Abbreviated New Drug Application / Food and Drug Administration / Medicare Part D / Pharmaceuticals policy / Pharmaceutical sciences / Pharmacology


ASPE ISSUE BRIEF Some Observations Related to the Generic Drug Market May 6, 2015 Introduction and Context The incentive for a manufacturer of a brand-name prescription drug to undertake measures that
Add to Reading List

Document Date: 2015-05-06 14:57:46

Open Document

File Size: 167,27 KB

Share Result on Facebook

City

New York / /

Company

Wall Street Journal / Forest Laboratories LLC / Dampen Generic Competition Actavis / Actavis PLC / Merck / New England Journal / IMS Health / New York Times / /

Continent

America / /

Country

United States / /

Currency

USD / /

Event

Product Recall / Product Issues / FDA Phase / Reorganization / /

Facility

Pharmacy Benefit Managers / Shed Medco / /

IndustryTerm

important tools / brand-name products / once-a-day product / prescription drug products / generic product / less expensive generic product / reformulated product / brand-name innovator products / Web Exclusive / brand-name product / target / brand-name manufacturer / generic drug manufacturer / line extension product / pharmaceutical markets / insurance premiums / pharmaceutical innovation / public insurance programs / brand-name pharmaceutical manufacturers / generic drug products / generic products / /

MedicalCondition

dementia / moderate-tosevere dementia / moderate-to-severe dementia / Alzheimer’s disease / chronic condition / hypertension / disease / severe chronic illness / Alzheimer disease / /

Organization

Drug-Benefits Unit / National Bureau of Economic Research / Federal Trade Commission / Congressional Budget Office / Medicare / Congress / Bureau of Competition / federal government / Generic Pharmaceutical Association / UN Court / House Committee on Energy and Commerce / FDA / Department of Health and Human Services office / increase spending by Medicare / /

Person

David Balto / Richard G. Frank / Catherine Koss / Ernst R. Berndt / D. Reiffen / M. Ward / Julie M. Donohue / /

Position

pharmacist / physician / Director Policy / Assistant Secretary for Planning / federal district judge / Policy Director / /

Product

Namenda XR / Vasotec / Namenda / Namenda IR / increase spending for Namenda / /

PublishedMedium

Health Economics / Public Law / New York Times / Review of Economics and Statistics / The New England Journal of Medicine / Wall Street Journal / /

TVStation

Kyle / /

Technology

drug discovery / /

URL

http /

SocialTag